| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/20/1997 | WO1997005892A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | WO1997005878A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005877A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | WO1997005865A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 02/20/1997 | WO1997005862A2 Use of basic amino acids and derivatives for lowering ceramide levels |
| 02/20/1997 | WO1997005861A1 Calcium-containing agent for intestinal phosphate binding and process for producing it |
| 02/20/1997 | WO1997002730A3 Enamel matrix related polypeptide |
| 02/20/1997 | WO1996040081A3 Oral delivery of gene constructs |
| 02/20/1997 | CA2229098A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 02/20/1997 | CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | CA2228650A1 Use of betaglycan to reduce scarring |
| 02/20/1997 | CA2228136A1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | CA2228050A1 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use |
| 02/20/1997 | CA2227204A1 Human mp52 arg protein |
| 02/20/1997 | CA2213773A1 Imidazopyridine derivatives |
| 02/19/1997 | EP0758644A1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives |
| 02/19/1997 | EP0758452A1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 02/19/1997 | EP0758330A1 Biphenylcarboxamides useful as 5-ht1d antagonists |
| 02/19/1997 | EP0758329A1 Morpholine derivatives and their use as antagonists of tachikinins |
| 02/19/1997 | EP0758245A1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori |
| 02/19/1997 | EP0758243A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa |
| 02/19/1997 | EP0758238A1 Spiro-substituted azacycles as neurokinin-3 antagonists |
| 02/19/1997 | EP0758225A1 Chewable anti-gastric acidity pastilles |
| 02/19/1997 | CN1143386A Transforming growth factor alpha-H1 |
| 02/19/1997 | CN1143319A Compound and methods for treatment of cardiovascular, inflammatory and immune disorders |
| 02/19/1997 | CN1034077C Preparation of new pyrido|2,3-f¨|1,4¨ thiazepines |
| 02/18/1997 | US5604247 Chromone Derivatives |
| 02/18/1997 | US5604245 Use of 4-amino-1-(2-pyridyl)piperidines for the preparation of a medicament for the treatment of conditions deriving from disorders of the serotoninergic systems mediated by 5-HT3 receptors |
| 02/18/1997 | US5604231 Non-steroidal antiinflammatory agents, dopaminergic agents; side effect reduction |
| 02/18/1997 | US5604221 Treating congestive heart failure, irritable bowel syndrome |
| 02/18/1997 | US5604203 Analogs of peptide YY and uses thereof |
| 02/18/1997 | US5604103 Kit for detection of clinical marker in kidney stone disease |
| 02/18/1997 | US5603943 Physiologically active substance homogeneously dispersed in and adsorbed on polyvalent metal carrier of specified particle size |
| 02/18/1997 | US5603930 Lactobacillus johnsonii CNCM I-1225 |
| 02/13/1997 | WO1997005285A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005279A1 Methods of predicting the outcome of infection |
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | WO1997005129A1 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same |
| 02/13/1997 | WO1997004792A1 Bowman-birk inhibitor compositions for treatment of imflammatory disease |
| 02/13/1997 | WO1997004779A1 Quinolones and their therapeutic use |
| 02/13/1997 | WO1997004768A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | WO1996035774A3 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/13/1997 | DE19529612A1 Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate Sulfonyl or sulfinyl derivatives benzoylguanidine |
| 02/13/1997 | CA2228298A1 Non-ionic surfactant vesicles as therapeutic agent |
| 02/13/1997 | CA2228056A1 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridinecarboxamide, process for preparation thereof and pharmaceutical composition containing said compound |
| 02/13/1997 | CA2227769A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | CA2225552A1 Quinolones and their therapeutic use |
| 02/13/1997 | CA2223968A1 Bowman-birk inhibitor compositions for treatment of inflammatory disease |
| 02/12/1997 | EP0757674A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 02/12/1997 | EP0757670A1 Benzamide derivatives as vasopressin antagonists |
| 02/12/1997 | CN1142854A C5a receptor antagonists having substantially no agonist activity |
| 02/12/1997 | CN1142831A Novel 2-substituted indane-2-mercaploacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142826A Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142819A Morpholine and thiomorpholine tachykinin receptor antagonists |
| 02/12/1997 | CN1142817A 1N-alkyl-N-arylpyrimidinamines and derivatives thereof |
| 02/12/1997 | CN1142765A inflammatory cytokine production inhibitor containing polyprenyl derivative as active ingredient |
| 02/12/1997 | CN1142504A Fluoridated micellar casein |
| 02/12/1997 | CN1142496A New thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/12/1997 | CN1142391A Oral liquid "Shuganlidan" for normalizing liver and secretion |
| 02/11/1997 | US5602253 Peptides derivatives |
| 02/11/1997 | US5602179 Optically-active derivatives of (R) 5-pentylamino-5-oxopentanoic acid with antagonistic activity towards cholecystokinin and a method for their preparation |
| 02/11/1997 | US5602154 Administering an enzyme inhibitor treating degenerative diseases |
| 02/11/1997 | US5602132 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 02/11/1997 | US5602129 N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
| 02/11/1997 | US5602024 DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof |
| 02/11/1997 | US5601848 Administering bismuth compound |
| 02/11/1997 | US5601804 Antiplaque agent |
| 02/11/1997 | CA2054212C Method for polymerization of epoxide compounds |
| 02/06/1997 | WO1997004117A1 Liver-specific adenovirus expression vector |
| 02/06/1997 | WO1997004009A1 Colostrum derived growth factor |
| 02/06/1997 | WO1997003984A1 Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] |
| 02/06/1997 | WO1997003973A1 4,5-diaryl oxazole derivatives |
| 02/06/1997 | WO1997003783A1 Metalloproteinase inhibitors |
| 02/06/1997 | WO1997003703A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | WO1997003699A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
| 02/06/1997 | WO1997003687A1 SOLUBLE LYMPHOTOXIN-β RECEPTORS AND ANTI-LYMPHOTOXIN RECEPTOR AND LIGAND ANTIBODIES, AS THERAPEUTIC AGENTS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASE |
| 02/06/1997 | WO1997003672A1 THERAPEUTIC USE OF d-threo-METHYLPHENIDATE |
| 02/06/1997 | WO1997003653A1 Enterogenin pharmaceutical form |
| 02/06/1997 | WO1996037210A3 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field |
| 02/06/1997 | DE19528524A1 Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung Calcium-containing phosphate binding agents for intestinal and process for its preparation |
| 02/06/1997 | CA2227477A1 Soluble lymphotoxin-.beta. receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 02/06/1997 | CA2227442A1 4,5-diaryl oxazole derivatives |
| 02/06/1997 | CA2227065A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 02/06/1997 | CA2226926A1 Liver-specific adenovirus expression vector |
| 02/06/1997 | CA2223629A1 Therapeutic use of d-threo-methylphenidate |
| 02/06/1997 | CA2200295A1 Enterogenin pharmaceutical form |
| 02/05/1997 | EP0756627A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |
| 02/05/1997 | EP0756605A1 Peptides as therapeutic agents for the treatment of auto-immune diseases |
| 02/05/1997 | EP0756595A1 Substituted 1,3-oxathiolanes with antiviral properties |
| 02/05/1997 | CN1142228A Novel amino acid derivatives, method of producing same and pharmaceutical compositions containing these compounds |
| 02/05/1997 | CN1142226A Novel heterocyclic compounds |
| 02/05/1997 | CN1142183A A method of treating neurogenic inflammation |
| 02/05/1997 | CN1141921A Chromone derivative |
| 02/05/1997 | CN1141802A Capsule for recovering stomach and production method thereof |
| 02/05/1997 | CN1141797A Tincture for treatment of toothache |
| 02/05/1997 | CN1141782A Ready-made Chinese medicine for treatment of stomach trouble |
| 02/05/1997 | CN1141773A Preparation of medicine containing 6-oxo-azitropilidene indole |